This is the basis for analysts’ expectations of $12.9 billion in sales this year (up from $5 billion last year). Moreover, in 2022 they forecast $32.9 billion. That represents a 155% rise in sales year over year. It also puts SENS stock on a forward price-t...
At a market cap of $974 million SENS stock trades for 30 times forward revenue multiple. But consider this. One of its main competitors, DexCom now has a $35 billion market cap and trades at 15 times 2021 forecast sales of $2.81 billion. Moreover, as I pointed out...